EXCLUSIVE license agreementExclusive License Agreement • February 9th, 2011 • Biopower Operations Corp • Florida
This Agreement (the "Agreement"), dated November 30, 2010 (the Effective Date) is entered into by and between Clenergen Corporation, a Nevada corporation and public company (Licensor) and BioPower Corporation, a Florida corporation (Licensee).
EMPLOYMENT AGREEMENTEmployment Agreement • February 9th, 2011 • Biopower Operations Corp • Florida
THIS EMPLOYMENT AGREEMENT ("Agreement") is made and entered into as of the 5th day of January, 2011 by and between BIOPOWER, a Nevada corporation (hereinafter called the " Company "), and Dale Shepherd (hereinafter called the "Executive").
LOCK-UP AGREEMENTLock-Up Agreement • February 9th, 2011 • Biopower Operations Corp
EXCLUSIVE FULLY PAID UP LICENSE AGREEMENT Between GREEN OIL PLANTATIONS LTD. And BIOPOWER OPERATIONS CORPORATION January 27, 2011Exclusive Fully Paid Up License Agreement • February 9th, 2011 • Biopower Operations Corp • Florida
This Agreement (the "Agreement"), dated January 27, 2011 (the Effective Date) is entered into by and between Green Oil Plantations Ltd., a United Kingdom corporation and their affiliates, associates and successors (“Licensor” and “Green Oil”), UK Head Office: The Colchester Centre, Hawkins Road, Colchester, CO2 8JX, UK, Company number: 07205772, registered in England and Wales with a registered address at 3 Warners Mill, Silks Way, Braintree, CM7 3GB, England and BioPower Operations Corporation, a Nevada corporation, collectively, (“Licensee” and “BioPower”) located at 5379 Lyons Rd. Suite 301, Coconut Creek, Florida 33073 USA.
SUBSCRIPTION AGREEMENT FOR THE PURCHASE OF SHARESSubscription Agreement • February 9th, 2011 • Biopower Operations Corp • Nevada
BioPower Operations Corporation, a Nevada corporation (the “Company”), is offering (this “Offering”) for sale to “accredited investors” as the term is defined under Regulation D promulgated under the Securities Act of 1933, as amended (the “Act”), Shares for a purchase price of $0.50 per Share, of the Company’s common stock, par value $0.0001 per share (“Common Stock”).
